Video: VORTEX® Non-Electrostatic Holding Chamber
A YouTube video is loaded here. If you cannot see the video window, it is because you do not allow external content in your settings. For more information, please see our Privacy Policy.
Metered dose inhalers are an integral part of respiratory therapy, but require hand-breath coordination for effective delivery of medication. PARI VORTEX® helps minimize the technique and breath coordination required with MDIs by creating a space between the MDI and the mouth allowing the speed of the medication to slow as well as suspending the medication in the chamber for a short period. This allows you to breathe normally and maximize medication delivery to your lungs.
A YouTube video is loaded here. If you cannot see the video window, it is because you do not allow external content in your settings. For more information, please see our Privacy Policy.
Users
Adult patients
What's Included
VORTEX® non-electrostatic holding chamber, mouthpiece cap, Instructions for Use
Part Number: 051F7000
HCPCS Code: A4627
“*for illustrative purposes only
Downloads
Users
Pediatric patients age 1-2
What's Included
VORTEX non-electrostatic holding chamber with toddler pediatric mask, mouthpiece cap, Instructions for Use
Part Number: 051F7100
HCPCS Code: A4627
Downloads
Users
Pediatric patients age 3-6
What's Included
VORTEX non-electrostatic holding chamber with child pediatric mask, mouthpiece cap, Instructions for Use
Part Number: 051F7200
HCPCS Code: A4627
Downloads
Users
Patients age 7+
What's Included
VORTEX non-electrostatic holding chamber with adult mask, mouthpiece cap, Instructions for Use
Part Number: 051F7300
HCPCS Code: A4627
Downloads
Medication deposited in the throat with MDI alone vs. MDI with VORTEX1
Key Findings:
VORTEX significantly reduces medication deposition in the mouth and back of the throat, which may cause unwanted side effects, vs. MDI alone.
MDI alone vs. VORTEX with MDI vs. Optichamber Diamond with MDI1
Key Findings:
VORTEX delivers a higher respirable drug dose than MDI alone and OptiChamber Diamond.
1Measurements according to Ph. Eur. 2.9.18 and USP 601: Next Generation Impactor; const. flow 30l/min; 50 ± 5 % relative humidity and 23 ± 2 °C: 3 test devices each measured in triplicates (n=3x3=9); pMDI Sultanol® (100μg Salbutamol, GlaxoSmithKline);
* All registered marks and trademarks belong to their respective companies
.
© 2024 PARI Respiratory Equipment, Inc.
